Diamyd Medical AB (FRA:DMN) EBIT: €-25.93 Mil (TTM As of May. 2026)

Diamyd Medical AB  (FRA:DMN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Diamyd Medical AB's annualized ROC % for the quarter that ended in May. 2026 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (May. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Diamyd Medical AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2026 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (May. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Diamyd Medical AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamyd Medical AB EBIT Related Terms

The historical data trend for Diamyd Medical AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamyd Medical AB EBIT Chart

Diamyd Medical AB Annual Data
	Trend	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23	Aug24	Aug25
EBIT		Get a 7-Day Free Trial					5.93	-9.82	-9.83	-13.26	-15.23

Diamyd Medical AB Quarterly Data
	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26	May26
EBIT	Get a 7-Day Free Trial															-3.95	-4.02	-4.44	-5.86	-11.61

FRA:DMN vs VRTX, REGN, RVMD: EBIT Comparison

For the Biotechnology subindustry, Diamyd Medical AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diamyd Medical AB EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's EV-to-EBIT falls into.

Diamyd Medical AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-25.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamyd Medical AB Business Description